Advent Life Sciences

Massachusetts
cb
Firm Location:Massachusetts • Cambridge, Massachusetts • Los Altos, California • Paris, France • London • Princeton, New Jersey • Oxford, United Kingdom
Investor Firms That Co-Invest with Advent Life Sciences
Atlas VenturePolaris PartnersSR OneNovartis Venture FundARCH Venture PartnersSamsara BioCapitalGlobal VenturesPureos Bioventures
Advent Life Sciences Team
Photo of Laura A. Lane, Principal at Advent Life Sciences
Laura A. Lane
Sweet spot: $1M
Range: $25K - $5.0M
Investors in Oxford (United Kingdom)
Investors in BioTech, Investors in BioTech
to see your intro paths to Laura
Photo of Don Drakeman, Venture Partner at Advent Life Sciences
Don Drakeman
Advent Life Sciences·Venture Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in Princeton (NJ)
Investors in BioTech, Investors in BioTech
to see your intro paths to Don
Photo of Alain Huriez, Venture Partner at Advent Life Sciences
Alain Huriez
Advent Life Sciences·Venture Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in Paris (France)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT
to see your intro paths to Alain
Photo of Satish Jindal, General Partner at Advent Life Sciences
Satish Jindal
Advent Life Sciences·General Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in Cambridge (MA)
Investors in BioTech, Investors in BioTech, Investors in Boston / New England (Other Lists)
to see your intro paths to Satish
Photo of Karen LaRochelle, Venture Partner at Advent Life Sciences
Karen LaRochelle
Advent Life Sciences·Venture Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in Princeton (NJ)
Investors in BioTech, Investors in BioTech, Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Karen
Photo of Philomena Lip, Analyst at Advent Life Sciences
Philomena Lip
Sweet spot: $1M
Range: $25K - $5.0M
Investors in London
Investors in BioTech, Investors in BioTech, Investors in London (Other Lists)
to see your intro paths to Philomena
Photo of Roy Lobb, Venture Partner at Advent Life Sciences
Roy Lobb
Advent Life Sciences·Venture Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in Massachusetts
Investors in BioTech, Investors in BioTech
to see your intro paths to Roy
Photo of Kaasim Mahmood, Partner at Advent Life Sciences
Kaasim Mahmood
Sweet spot: $1M
Range: $25K - $5.0M
Investors in London
Investors in FinTech, Investors in FinTech, Investors in London (Other Lists)
to see your intro paths to Kaasim
Photo of Shahzad Malik, General Partner at Advent Life Sciences
Shahzad Malik
Advent Life Sciences·General Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in London
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in London (Other Lists), Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Shahzad
Photo of Raj Parekh, General Partner at Advent Life Sciences
Raj Parekh
Advent Life Sciences·General Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in Los Altos (CA)
Investors in BioTech, Investors in BioTech, Investors in SaaS, Investors in SaaS, Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Raj
Photo of Dominic Schmidt, General Partner at Advent Life Sciences
Dominic Schmidt
Advent Life Sciences·General Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in London
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in London (Other Lists)
to see your intro paths to Dominic
Photo of Alan Walts, Venture Partner at Advent Life Sciences
Alan Walts
Advent Life Sciences·Venture Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in Massachusetts
Investors in BioTech, Investors in BioTech
to see your intro paths to Alan